203 related articles for article (PubMed ID: 22225786)
1. Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma.
Ohe M; Yokose T; Sakuma Y; Miyagi Y; Okamoto N; Osanai S; Hasegawa C; Nakayama H; Kameda Y; Yamada K; Isobe T
Diagn Pathol; 2012 Jan; 7():3. PubMed ID: 22225786
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis.
Zhang J; Liang Z; Gao J; Luo Y; Liu T
Histopathology; 2011 Dec; 59(6):1204-14. PubMed ID: 22175900
[TBL] [Abstract][Full Text] [Related]
3. Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.
Ohe M; Yokose T; Sakuma Y; Osanai S; Hasegawa C; Washimi K; Nawa K; Woo T; Hamanaka R; Nakayama H; Kameda Y; Yamada K; Isobe T
Diagn Pathol; 2011 Sep; 6():92. PubMed ID: 21955603
[TBL] [Abstract][Full Text] [Related]
4. High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review.
Morales-Oyarvide V; Mino-Kenudson M
Curr Opin Pulm Med; 2014 Jul; 20(4):317-23. PubMed ID: 24852329
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary adenocarcinoma with micropapillary pattern: a clinicopathologic and immunohistochemical study].
Zhang J; Liang ZY; Luo YF; Wan JW; Cao JL; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):651-6. PubMed ID: 20078967
[TBL] [Abstract][Full Text] [Related]
6. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T
J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266
[TBL] [Abstract][Full Text] [Related]
7. Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma.
Kamiya K; Hayashi Y; Douguchi J; Hashiguchi A; Yamada T; Izumi Y; Watanabe M; Kawamura M; Horinouchi H; Shimada N; Kobayashi K; Sakamoto M
Mod Pathol; 2008 Aug; 21(8):992-1001. PubMed ID: 18516041
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary adenocarcinomas with micropapillary component significantly correlate with recurrence, but can be well controlled with EGFR tyrosine kinase inhibitors in the early stages.
Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Fujimoto M; Tsuruyama T; Date H; Haga H
Lung Cancer; 2013 Jul; 81(1):53-9. PubMed ID: 23632273
[TBL] [Abstract][Full Text] [Related]
9. [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].
Sun PL; Liu JN; Cao LQ; Yao M; Gao HW
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):303-308. PubMed ID: 28468034
[No Abstract] [Full Text] [Related]
10. Association of c-Met phosphorylation with micropapillary pattern and small cluster invasion in pT1-size lung adenocarcinoma.
Koga K; Hamasaki M; Kato F; Aoki M; Hayashi H; Iwasaki A; Kataoka H; Nabeshima K
Lung Cancer; 2013 Dec; 82(3):413-9. PubMed ID: 24094902
[TBL] [Abstract][Full Text] [Related]
11. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
[TBL] [Abstract][Full Text] [Related]
12. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
[TBL] [Abstract][Full Text] [Related]
13. A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis.
Tsutsumida H; Nomoto M; Goto M; Kitajima S; Kubota I; Hirotsu Y; Wakimoto J; Hollingsworth MA; Yonezawa S
Mod Pathol; 2007 Jun; 20(6):638-47. PubMed ID: 17431413
[TBL] [Abstract][Full Text] [Related]
14. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
[TBL] [Abstract][Full Text] [Related]
15. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.
Motoi N; Szoke J; Riely GJ; Seshan VE; Kris MG; Rusch VW; Gerald WL; Travis WD
Am J Surg Pathol; 2008 Jun; 32(6):810-27. PubMed ID: 18391747
[TBL] [Abstract][Full Text] [Related]
16. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma.
Qu Y; Che N; Zhao D; Zhang C; Su D; Zhou L; Zhang L; Wang C; Zhang H; Wei L
Tumour Biol; 2015 Aug; 36(8):6417-24. PubMed ID: 25813151
[TBL] [Abstract][Full Text] [Related]
18. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
[TBL] [Abstract][Full Text] [Related]
19. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
[TBL] [Abstract][Full Text] [Related]
20. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]